Effects of morroniside isolated from Corni Fructus on renal lipids and inflammation in type 2 diabetic mice

Chan Hum Park1, Jeong Sook Noh, Takashi Tanaka

  • 1Institute of Natural Medicine, University of Toyama, Toyama, Japan.

Abstract

Insights

Morroniside, derived from Corni Fructus, effectively reduced kidney lipids and inflammation in type 2 diabetic mice. This natural compound shows promise for managing diabetic nephropathy by improving lipid metabolism and alleviating oxidative stress.

Area of Science:

  • Pharmacology
  • Nephrology
  • Metabolic Diseases

Background:

  • Hyperglycemia in type 2 diabetes mellitus (T2DM) leads to significant renal complications, including abnormal lipid metabolism and inflammation.
  • Diabetic nephropathy is a major cause of end-stage renal disease, necessitating novel therapeutic strategies.

Purpose of the Study:

  • To investigate the therapeutic effects of morroniside, a compound isolated from Corni Fructus, on renal lipid accumulation and inflammation in a mouse model of T2DM.
  • To elucidate the underlying mechanisms by which morroniside impacts lipid homeostasis and oxidative stress in the diabetic kidney.

Main Methods:

  • Administration of morroniside (20 or 100 mg/kg/day) orally to db/db mice (T2DM model) for 8 weeks.
  • Comparison with vehicle-treated db/db mice and non-diabetic m/m mice.
  • Assessment of serum and renal biochemical parameters, including lipids and glucose.
  • Measurement of protein expression related to lipid metabolism (SREBP-1, SREBP-2) and inflammation (NF-κB, COX-2, iNOS).
  • Evaluation of oxidative stress markers, including reactive oxygen species (ROS), lipid peroxidation, and glutathione levels.

Main Results:

  • Morroniside treatment resulted in significant, dose-dependent reductions in serum triglyceride and renal glucose and lipid levels.
  • The compound normalized the expression of sterol regulatory element-binding proteins (SREBP-1 and SREBP-2), indicating improved lipid homeostasis.
  • Morroniside inhibited the formation of reactive oxygen species and lipid peroxidation while increasing the ratio of reduced to oxidized glutathione, suggesting alleviation of oxidative stress.
  • Down-regulation of key inflammatory markers, including nuclear factor-kappa B p65 (NF-κB p65), cyclooxygenase-2 (COX-2), and inducible nitric oxide synthase (iNOS), was observed at the higher dose.

Conclusions:

  • Morroniside demonstrates significant potential in ameliorating abnormal lipid metabolism and inflammation in the kidneys of type 2 diabetic mice.
  • The protective effects are likely mediated through the inhibition of oxidative stress and inflammatory pathways.
  • Corni Fructus-derived morroniside represents a promising natural compound for managing diabetic kidney disease.

Related Concept Videos